Indication
Letterer-Siwe disease
Letterer-Siwe disease is an acute, severe, multisystem form of Langerhans cell histiocytosis characterized by the clonal proliferation and widespread tissue infiltration of pathologic dendritic mononuclear cells. Read more about Letterer-Siwe disease
4 drugs 4 manufacturers
Drugs that treat it
Common Letterer-Siwe disease therapies.
OPZELURA (vinblastine sulfate)
VINBLASTINE SULFATE
VINBLASTINE SULFATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLetterer-Siwe disease is an acute, severe, multisystem form of Langerhans cell histiocytosis characterized by the clonal proliferation and widespread tissue infiltration of pathologic dendritic mononuclear cells.
It primarily affects infants and children younger than two years of age, presenting as a disseminated disorder involving high-risk organ systems.
Clinically, it manifests with constitutional symptoms such as fever and failure to thrive, alongside a characteristic scaly or purpuric seborrheic-like cutaneous eruption, lymphadenopathy, hepatosplenomegaly, cytopenias from bone marrow infiltration, and potential pulmonary or skeletal involvement.
Without prompt systemic intervention, this disseminated histiocytic proliferation carries a high risk of rapidly progressive organ dysfunction and significant mortality.
- nih.gov
Letterer-Siwe disease is an acute, severe, multisystem form of Langerhans cell histiocytosis characterized by the clonal proliferation and widespread tissue infiltration of pathologic dendritic mononuclear cells Without prompt systemic intervention, this disseminated histiocytic proliferation carries a high risk of rapidly progressive organ dysfunction and significant mortality
- merckmanuals.com
Letterer-Siwe disease is an acute, severe, multisystem form of Langerhans cell histiocytosis characterized by the clonal proliferation and widespread tissue infiltration of pathologic dendritic mononuclear cells It primarily affects infants and children younger than two years of age, presenting as a disseminated disorder involving high-risk organ systems Clinically, it manifests with constitutional symptoms such as fever and failure to thrive, alongside a characteristic scaly or purpuric seborrh...
- nih.gov
It primarily affects infants and children younger than two years of age, presenting as a disseminated disorder involving high-risk organ systems Clinically, it manifests with constitutional symptoms such as fever and failure to thrive, alongside a characteristic scaly or purpuric seborrheic-like cutaneous eruption, lymphadenopathy, hepatosplenomegaly, cytopenias from bone marrow infiltration, and potential pulmonary or skeletal involvement
Personalize your experience
Follow Letterer-Siwe disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.